BDWCC
LLY icon

B&D White Capital Company’s Eli Lilly LLY Stock Holding History

B&D White Capital Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$552K Sell
600
-72
-11% -$73K 0.07% 57
2025
Q4 		$722K Sell
672
-200
-23% -$191K 0.08% 59
2025
Q3 		$665K Buy
+872
New +$649K 0.09% 61

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

B&D White Capital Company's LLY Position: Q1 2026 in Review

B&D White Capital Company reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $73K and leaving 600 shares worth $552K. The position accounts for 0.07% of the portfolio, ranked #57.

B&D White Capital Company first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. The position peaked at $722K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • B&D White Capital Company held 600 shares of Eli Lilly worth $552K as of Q1 2026.
  • B&D White Capital Company sold 72 Eli Lilly shares in Q1 2026, an estimated $73K.
  • Eli Lilly made up 0.07% of B&D White Capital Company's portfolio in Q1 2026, its #57 holding.
  • B&D White Capital Company first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • B&D White Capital Company's Eli Lilly position peaked at $722K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on B&D White Capital Company's 13F filing for Q1 2026, filed 13 May 2026.